MPNST with NF1 mutation leads to the promotion of the Rapidly Accelerated Fibrosarcoma/Mitogen-Activated Protein Kinase/Extracellular Signal (RAS/RAF/MEK/ERK) pathway [44]. The gene discussed is MAPK1; the disease is malignant peripheral nerve sheath tumor.